Related Experiment Video
Updated: Jul 16, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
The effect of methotrexate on the expression of cell adhesion molecules and activation molecule CD69 in psoriasis
B Torres-Alvarez1, J P Castanedo-Cazares, C Fuentes-Ahumada
1Department of Dermatology, Hospital Central, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, Av. Venustiano Carranza 2395, CP 78240 San Luis Potosí, Mexico. torresmab@yahoo.com.mx
Background:
The mechanism of the action of methotrexate (MTX) in the treatment of psoriasis has not been completely elucidated.
Objective:
To assess the effect of MTX on the expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), E-selectin, activation molecule CD69 and T-cell phenotype in skin specimens from patients with psoriasis.
Methods:
We performed an immunohistochemical analysis of the expression of T-cell phenotype and cell adhesion/activation molecules in skin biopsies from patients with psoriasis treated with a fixed dose of MTX (12.5 mg/week). To determine data on the epidermal/dermal T-cell infiltration we carried out a manual quantification.
Results:
Skin samples prior to therapy showed a moderate to severe inflammatory infiltrate, mainly due to T lymphocytes with a helper/inducer (CD4) phenotype. Most of these cells also expressed ICAM-1 and VCAM-1. Blood vessels showed expression of E-selectin and VCAM-1, and keratinocytes were positive for ICAM-1 staining. The cell infiltrate was reduced after therapy, as well as the expression of cell adhesion molecules. However, we also noted the persistence of the T lymphocyte phenotype CD8(+), expressing the CD69 activation molecule, after the MTX treatment.
Conclusions:
MTX downregulates the expression of some adhesion molecules, a phenomenon that may contribute to its anti-inflammatory therapeutic effect in psoriasis. The infiltrating T cells post-treatment have an activated cytotoxic phenotype, which may suggest a pathogenic role in the continuation and/or recurrence of psoriasis.
Insights
Methotrexate (MTX) treatment for psoriasis reduces inflammatory T cells and adhesion molecules. However, activated cytotoxic T cells persist, potentially contributing to disease recurrence.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- The precise mechanism of methotrexate (MTX) in treating psoriasis remains unclear.
- Understanding MTX's effects on immune cell interactions is crucial for psoriasis management.
Purpose of the Study:
- To investigate MTX's impact on adhesion molecules (ICAM-1, VCAM-1, E-selectin) and T-cell activation (CD69) in psoriasis.
- To analyze changes in T-cell phenotypes within skin lesions after MTX therapy.
Main Methods:
- Immunohistochemical analysis of skin biopsies from psoriasis patients treated with MTX (12.5 mg/week).
- Manual quantification of epidermal and dermal T-cell infiltration.
- Assessment of cell adhesion and activation molecule expression.
Main Results:
- Pre-treatment biopsies showed significant T-cell infiltration (CD4+ phenotype) expressing ICAM-1 and VCAM-1.
- MTX therapy reduced overall T-cell infiltrate and adhesion molecule expression.
- Post-treatment, CD8+ T cells expressing the CD69 activation molecule persisted.
Conclusions:
- MTX downregulates specific adhesion molecules, contributing to its anti-inflammatory effects in psoriasis.
- Persistent activated cytotoxic T cells (CD8+) post-MTX may play a role in psoriasis chronicity or relapse.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Therapeutic Drug Monitoring: Affecting Factors
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...